Τρίτη 26 Σεπτεμβρίου 2017

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers

British Journal of Cancer 117, 913 (26 September 2017). doi:10.1038/bjc.2017.274

Authors: Ashley M Hopkins, Andrew Rowland, Ganessan Kichenadasse, Michael D Wiese, Howard Gurney, Ross A McKinnon, Chris S Karapetis & Michael J Sorich



from Cancer via ola Kala on Inoreader http://ift.tt/2xgWp6u
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου